Keyphrases
Prostate Cancer
100%
Stable Isotope Labeling
100%
Dimethylation
100%
Patients with Prostate Cancer
100%
Urine Proteome
100%
Enlarged Prostate
80%
Urinary Sample
60%
Deoxypyridinoline
60%
Prostate Cancer Patients
40%
Pyridinoline
40%
Malignancy
20%
Healthy Volunteers
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Proteomic Analysis
20%
Patient Management
20%
Low Sensitivity
20%
Diagnostic Accuracy
20%
Sensitivity Specificity
20%
Student's T-test
20%
Diagnostic Performance
20%
Screening Test
20%
Diagnostic Biomarker
20%
Biomarker Discovery
20%
Receiver Operating Characteristic Curve
20%
Liquid Chromatography
20%
Diagnostic Process
20%
Potential Identification
20%
Proteomic Approach
20%
Osteopontin
20%
Prostate Cancer Screening
20%
Malignant Cancer
20%
Analytical Performance
20%
Untargeted Metabolomics
20%
Prostate-specific Antigen Testing
20%
New Biomarkers
20%
Benign Prostate Disease
20%
High-resolution Tandem Mass Spectrometry
20%
Dysregulated Pathways
20%
Locally Advanced Cancer
20%
Benjamini-Hochberg
20%
Prostate Cancer Staging
20%
Prothrombin
20%
Differential Display Analysis
20%
Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Isotope Labeling
100%
Cross-Link
66%
Pyridinoline
66%
Tandem Mass Spectrometry
33%
Tandem Mass Spectrometry
33%
Normal Human
33%
Differential Display
33%
Biomarker Discovery
33%
Liquid Chromatography-Mass Spectrometry
33%
Prostate-Specific Antigen
33%
Screening Test
33%
Osteopontin
33%
Liquid Chromatography
33%
Metabolomics
33%
Student's t-Test
33%
Prothrombin
33%